All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

184

Reset

184 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • PalazestrantOP-1250Phase 32 trials

    Olema Oncology, Inc. · Breast Cancer, Metastatic Breast Cancer, ER Positive Breast Cancer

  • PF-07248144Phase 32 trials

    Pfizer · Locally Advanced or Metastatic ER+ HER2- Breast Cancer, Locally Advanced or Metastatic Castration-resistant Prostate Cancer, Locally Advanced or Metastatic Non-small Cell Lung Cancer

  • RYZ101Phase 32 trials

    RayzeBio, Inc. · Metastatic Breast Cancer, HER2-negative Breast Cancer, ER+ Breast Cancer

  • SV-BR-1-GMthe Bria-IMTPhase 32 trials

    BriaCell Therapeutics Corporation · Breast Cancer, Metastatic Breast Cancer, Breast Neoplasm

  • TOL2506Phase 32 trials

    Tolmar Inc. · Breast Cancer

  • XZP-3287Phase 32 trials

    Xuanzhu Biopharmaceutical Co., Ltd. · Advanced Breast Cancer

  • ZN-A-1041ZN-A-1041 Enteric, RO7771950Phase 32 trials

    Roche (Genentech) · HER2-positive Breast Cancer, Advanced Solid Tumors

  • BGB-43395Phase 31 trial

    BeOne Medicines (BeiGene) · HR+/HER2- Breast Cancer

  • DalpciclibPhase 31 trial

    Jiangsu HengRui Medicine Co., Ltd. · Breast Cancer

  • DalpiciclibPhase 31 trial

    Risen (Suzhou) Pharma Tech Co., Ltd. · Breast Cancer

  • FDA018-ADCPhase 31 trial

    Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. · Triple Negative Breast Cancer

  • Fixed of PertuzumabPhase 31 trial

    Roche (Genentech) · Early Breast Cancer, Locally Advanced Breast Cancer, Inflammatory Breast Cancer

  • GB491Phase 31 trial

    Genor Biopharma Co., Ltd. · Breast Cancer

  • GLSI-100Phase 31 trial

    Greenwich LifeSciences, Inc. · Breast Cancer

  • GQ1005Phase 31 trial

    GeneQuantum Healthcare (Suzhou) Co., Ltd. · HER2-positive Breast Cancer

  • Hemay022Phase 31 trial

    Tianjin Hemay Pharmaceutical Co., Ltd · Breast Cancer

  • HLX11Phase 31 trial

    Shanghai Henlius Biotech · Breast Cancer, Breast Neoplasms, HER2-positive Breast Cancer

  • HS627Phase 31 trial

    BioRay Pharmaceutical Co., Ltd. · Breast Cancer

  • HX22Phase 31 trial

    Shanghai Henlius Biotech · HER2 + Breast Cancer

  • JYP0035Phase 31 trial

    Chengdu JOYO pharma Co., Ltd. · Breast Cancer

  • NTQ1062Phase 31 trial

    Nanjing Chia-tai Tianqing Pharmaceutical · HR Positive/HER2 Negative Advanced or Metastatic Breast Cancer

  • RPH-051Phase 31 trial

    R-Pharm · Locally Advanced Breast Cancer, Metastatic Breast Cancer

  • SHR6390Phase 31 trial

    Jiangsu HengRui Medicine Co., Ltd. · Hormone Receptor Positive,Human Epidermal Receptor 2 Negative, Node-positive, High Risk, Early Stage,Female Breast Cancer

  • SIM0270Phase 31 trial

    Jiangsu Simcere Pharmaceutical Co., Ltd. · Locally Advanced or Metastatic Breast Cancer

  • SRG-514Phase 31 trial

    SURGE Therapeutics · TNBC - Triple-Negative Breast Cancer

  • ZovegalisibPhase 31 trial

    Relay Therapeutics, Inc. · PIK3CA Mutation, HER2- Negative Breast Cancer, Hormone Receptor Positive Tumor

  • SI-B003Phase 210 trials

    Sichuan Baili Pharmaceutical Co., Ltd. · Non-small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma, Squamous Cell Carcinoma of Head and Neck

  • RO7247669Tobemstomig, RG6139Phase 26 trials

    Roche (Genentech) · Solid Tumors, Metastatic Melanoma, Non-small Cell Lung Cancer

  • Dual-target CAR-NK cellsEB-DT-CAR-NK, Essen Biotech Dual-Target CAR-NKPhase 25 trials

    Beijing Biotech · HER2-positive Breast Cancer, Non-Small Cell Lung Cancer, Breast Cancer (Locally Advanced or Metastatic)

  • EvorpaceptALX148Phase 25 trials

    ALX Oncology Inc. · Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma, Breast Cancer, Metastatic

  • PalacaparibAZD9574Phase 25 trials

    AstraZeneca · Metastatic Prostate Cancer, Ovarian Cancer, Endometrial Cancer

  • Zelenectide pevedotinBT8009Phase 25 trials

    BicycleTx Limited · Breast Cancer, Non-Small Cell Lung Cancer, Advanced Solid Tumors

  • IL-2MDNA11, Interleukin-2 -albuminPhase 24 trials

    Grit Biotechnology · Advanced Solid Tumor, Unresectable Solid Tumor, Clear Cell Renal Cell Carcinoma

  • MHB039APhase 24 trials

    Minghui Pharmaceutical (Hangzhou) Ltd · Advanced Malignant Solid Tumor, Advanced Breast Cancer, Advanced Lung Cancer

  • ADCAntibody-drug conjugate, ADCE-D01Phase 23 trials

    MBrace Therapeutics · Prostate Cancer Castration-resistant Prostate Cancer, Breast Cancer, Colo-rectal Cancer

  • AK146D1Phase 23 trials

    Akeso · Advanced Non Small Cell Lung Cancer (NSCLC), Advanced Breast Cancer, Urothelial Carcinoma (UC)

  • AlisertibPB-8237, MLN8237Phase 23 trials

    Puma Biotechnology, Inc. · Hormone Receptor Positive HER-2 Negative Breast Cancer, Metastatic Breast Cancer, Recurrent Breast Cancer

  • BT5528nuzefatide pevedotinPhase 23 trials

    BicycleTx Limited · Advanced Solid Tumors, Advanced Solid Tumor Historically Known for High EphA2 Expression, Urothelial Cancer

  • GV20-0251Phase 23 trials

    GV20 Therapeutics · Endometrial Carcinoma (EC), Squamous Head and Neck Carcinoma, pMMR/MSS Adenocarcinoma of the Colon or Rectum

  • HRS-2189Phase 23 trials

    Jiangsu HengRui Medicine Co., Ltd. · Advanced Unresectable or Metastatic Breast Cancer, Breast Cancer, Prostate Cancer

  • MHB036CPhase 23 trials

    Minghui Pharmaceutical (Hangzhou) Ltd · Advanced Breast Cancer, Advanced Malignant Solid Tumor, Advanced Lung Cancer

  • PelareorepPhase 23 trials

    Oncolytics Biotech · Anal Cancer Metastatic, Squamous Cell Carcinoma of the Anus Stage Unspecified, Pancreatic Cancer Metastatic

  • SamuraciclibICEC0942, CT7001Phase 23 trials

    Carrick Therapeutics Limited · Metastatic Breast Cancer, Locally Advanced Breast Cancer, Breast Cancer

  • [177Lu]Lu-NeoBLutetium NeoB, [177Lu]-NeoBPhase 22 trials

    Novartis · Breast Cancer, Neoplasms

  • [68Ga]Ga-NeoBGallium NeoB, [68Ga]-NeoBPhase 22 trials

    Novartis · Breast Cancer, Neoplasms

  • AK138D1Phase 22 trials

    Akeso · Non-Small Cell Lung Cancer, Breast Cancer

  • AVZO-021Phase 22 trials

    Avenzo Therapeutics, Inc. · HR+/HER2- Breast Cancer, HR+, HER2-, Advanced Breast Cancer, Advanced Solid Tumor

  • B1962Phase 22 trials

    Tasly Biopharmaceuticals Co., Ltd. · Recurrent Platinum-resistant Epithelial Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Cervical Cancers

  • BLEX 404 LiquidPhase 22 trials

    BioLite, Inc. · Myelodysplastic Syndrome (MDS), Triple Negative Breast Cancer

  • BreakVaxPhase 22 trials

    BreakBio Corp · Triple-Negative Breast Cancer (TNBC), Glioblastoma (GBM)

NewerPage 2 of 4Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.